Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)

This grant invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are:

1) to improve SCLC therapeutics, focusing on understanding how the molecular vulnerabilities of this cancer could be used to develop targeted agent combinations

2) to gain a better understanding of the rapid development of clinical resistance to drug and radiation therapy. 

Funding: $450,000 total 

Duration: 5 years 

LOI (encouraged) due dates: 17.2.16, 17.10.16, 17.2.17, 17.10.17, 17.2.18, 17.10.18 

Full application due dates: 17.3.16, 17.11.16, 17.3.17, 17.11.17, 17.3.18, 17.11.18